Feb 24, 2022 / 05:30PM GMT
Patrick Bernard Donnelly - Citigroup Inc., Research Division - Senior Analyst
Well, great. Thank you, everyone, for joining us here at the Citi Healthcare Conference. I'm Patrick Donnelly, I cover the Tools, Diagnostics and CROs here at Citi. Happy to have Sam Samad, CFO of Illumina, with us today for this session. We'll do about 35 or 40 minutes of questions. Investors, if you have any questions, feel free to e-mail me. I will try to get them in. And Sam, I know you want to do a quick safe harbor. So I'll turn it over to you.
Sam A. Samad - Illumina, Inc. - CFO
Yes. Thanks, Patrick. Thanks for having me today. Really a pleasure to be with you. So I will do a safe harbor, and then we can go straight to the questions.
I've been asked to remind you that my comments today could include forward-looking statements. You should refer to our SEC filings for a discussion of the risks and uncertainties that could cause results to differ materially from our current expectations. It is our intent that all forward-looking statements regarding our financial results
Illumina Inc at Citi Healthcare Conference (Virtual) Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers